BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38002964)

  • 21. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
    Li Y; Li X; Liu X; Kang L; Liu X
    J Int Med Res; 2020 Sep; 48(9):300060520952621. PubMed ID: 32883129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mastocytosis and related disorders.
    Chiu A; Orazi A
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.
    Zheng Y; Nong L; Liang L; Wang W; Li T
    Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mastocytosis in children: a single-center long-term follow-up study.
    Popadic S; Lalosevic J; Lekic B; Gajić-Veljic M; Bonaci-Nikolic B; Nikolic M
    Int J Dermatol; 2023 May; 62(5):616-620. PubMed ID: 36807903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
    Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
    Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast Cell Burden in a Patient With Cutaneous Disease.
    Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature.
    Koga H; Kokubo T; Akaishi M; Iida K; Korematsu S
    Pediatr Dermatol; 2011; 28(5):542-6. PubMed ID: 20678092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood mastocytosis.
    Torrelo A; Alvarez-Twose I; Escribano L
    Curr Opin Pediatr; 2012 Aug; 24(4):480-6. PubMed ID: 22790101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical observations in cutan mastocytosis].
    Mihalik N; Hidvégi B; Hársing J; Várkonyi J; Csomor J; Kovalszky I; Marschalkó M; Kárpáti S
    Orv Hetil; 2013 Sep; 154(37):1469-75. PubMed ID: 24016753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kit Mutations: New Insights and Diagnostic Value.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic basis of mast cell activation disease - looking through a glass darkly.
    Molderings GJ
    Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
    Carter MC; Bai Y; Ruiz-Esteves KN; Scott LM; Cantave D; Bolan H; Eisch R; Sun X; Hahn J; Maric I; Metcalfe DD
    Br J Haematol; 2018 Dec; 183(5):775-782. PubMed ID: 30488427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mastocytosis: a comprehensive insight.
    VAN Gysel D; DE Maeseneer H; Oranje AP
    G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease.
    Rydz A; Lange M; Ługowska-Umer H; Sikorska M; Nowicki RJ; Morales-Cabeza C; Alvarez-Twose I
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
    Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
    Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine.
    Angus J; Leach IH; Grant J; Ravenscroft JC
    Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.